• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Th9细胞通过CCL20和STAT3途径在肝细胞癌中发挥促肿瘤作用。

A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.

作者信息

Tan Hongwu, Wang Shuyun, Zhao Ludong

机构信息

Department of Gastroenterology, Linyi People's Hospital, Shandong, China.

Operation Room, Linyi People's Hospital, Shandong, China.

出版信息

Clin Exp Pharmacol Physiol. 2017 Feb;44(2):213-221. doi: 10.1111/1440-1681.12689.

DOI:10.1111/1440-1681.12689
PMID:27797409
Abstract

Hepatocellular carcinoma (HCC) is a common and aggressive human malignancy. An imperative demand is present for a better understanding of the functions and regulations of the immune system and how they affect HCC pathogenesis. Recently, a group of interleukin 9 (IL-9)-producing CD4 T cells, termed Th9 cells, has been described in mice and humans with both tumour-inhibiting as well as tumour-promoting effects. The specific roles of Th9 cells in human HCC are not entirely understood. Here, we examined the frequencies and functions of IL-9-producing Th9 cells in HCC patients. We found that the frequencies of circulating IL-9-producing Th9 cells were significantly higher in HCC patients compared to in healthy individuals. In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues. Interestingly, HCC patients with higher tumour-infiltrating Th9 frequency had significantly shorter disease-free survival period after resection. Previously, high expression of CCL20 was associated with poor prognosis in HCC. CCL20 also induced epithelial-mesenchymal transition-like changes in HCC cells. We found that incubation of primary HCC cells with autologous Th9 significantly elevated the CCL20 production from tumour cells, which could be partially inhibited by suppressing STAT3. Together, this study suggested a tumour-promoting role of Th9 cells in HCC.

摘要

肝细胞癌(HCC)是一种常见且侵袭性强的人类恶性肿瘤。目前迫切需要更好地了解免疫系统的功能和调控机制,以及它们如何影响HCC的发病机制。最近,在小鼠和人类中都发现了一组产生白细胞介素9(IL-9)的CD4 T细胞,称为Th9细胞,它们具有肿瘤抑制和肿瘤促进双重作用。Th9细胞在人类HCC中的具体作用尚未完全明确。在此,我们检测了HCC患者中产生IL-9的Th9细胞的频率和功能。我们发现,与健康个体相比,HCC患者循环中产生IL-9的Th9细胞频率显著更高。在HCC患者中,肿瘤周围和肿瘤组织中产生IL-9的Th9细胞频率明显高于未受影响的肝组织。有趣的是,肿瘤浸润Th9细胞频率较高的HCC患者在切除术后无病生存期明显更短。此前,CCL20的高表达与HCC的不良预后相关。CCL20还可诱导HCC细胞发生上皮-间质转化样变化。我们发现,将原发性HCC细胞与自体Th9细胞共同孵育可显著提高肿瘤细胞CCL20的产生,而抑制STAT3可部分抑制这一过程。综上所述,本研究提示Th9细胞在HCC中具有促进肿瘤的作用。

相似文献

1
A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.Th9细胞通过CCL20和STAT3途径在肝细胞癌中发挥促肿瘤作用。
Clin Exp Pharmacol Physiol. 2017 Feb;44(2):213-221. doi: 10.1111/1440-1681.12689.
2
Interleukin-35 Suppresses Interleukin-9-Secreting CD4 T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma.白细胞介素-35 抑制乙型肝炎相关肝细胞癌患者分泌白细胞介素-9 的 CD4 T 细胞的活性。
Front Immunol. 2021 Jun 10;12:645835. doi: 10.3389/fimmu.2021.645835. eCollection 2021.
3
Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.趋化因子配体20通过上皮-间质转化促进肝细胞癌进展。
World J Gastroenterol. 2015 Jan 14;21(2):475-83. doi: 10.3748/wjg.v21.i2.475.
4
CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.CCL20-CCR6细胞因子网络促进晚期和转移性肝细胞癌中的调节性T细胞活性。
Scand J Immunol. 2016 Jan;83(1):33-7. doi: 10.1111/sji.12367.
5
Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.CC趋化因子MIP-3α在肝细胞癌中的表达增强及其临床意义
Scand J Immunol. 2006 Jun;63(6):468-77. doi: 10.1111/j.1365-3083.2006.001766.x.
6
[Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].[原发性肝癌患者CCL20/CCR6/Th17轴与血管侵袭及转移的关系]
Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):5-10.
7
Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.慢性乙型肝炎患者体内的调节性 T 细胞通过抑制抗肿瘤免疫反应来影响肝细胞癌的免疫发病机制。
J Viral Hepat. 2010 Mar;17 Suppl 1:34-43. doi: 10.1111/j.1365-2893.2010.01269.x.
8
Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.免疫细胞在乙型肝炎相关肝细胞癌手术切除后的预后作用取决于其定位和肿瘤大小。
J Immunother. 2016 Jan;39(1):36-44. doi: 10.1097/CJI.0000000000000104.
9
Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.在肝癌患者中,CD4(+) CD69(+) CD25(-) T 细胞的增加与肿瘤进展有关。
J Gastroenterol Hepatol. 2011 Oct;26(10):1519-26. doi: 10.1111/j.1440-1746.2011.06765.x.
10
Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.肝内白细胞介素-17+ T细胞与叉头框蛋白3+调节性T细胞协同作用促进肝细胞癌的发展并影响其预后。
J Gastroenterol Hepatol. 2014 Apr;29(4):851-9. doi: 10.1111/jgh.12418.

引用本文的文献

1
Chemokines: Orchestration of the Tumor Microenvironment and Control of Hepatocellular Carcinoma Progression.趋化因子:肿瘤微环境的调控与肝细胞癌进展的控制
Cancer Med. 2025 Apr;14(7):e70789. doi: 10.1002/cam4.70789.
2
miR-183-5p-enriched extracellular vesicles promote the crosstalk between hepatocellular carcinoma cell and endothelial cell via SIK1/PI3K/AKT and CCL20/CCR6 signaling pathways.富含miR-183-5p的细胞外囊泡通过SIK1/PI3K/AKT和CCL20/CCR6信号通路促进肝癌细胞与内皮细胞之间的串扰。
Front Oncol. 2025 Mar 6;15:1532239. doi: 10.3389/fonc.2025.1532239. eCollection 2025.
3
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Th17细胞在癌症中的作用:免疫抑制剂还是抗肿瘤盟友?
Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9.
4
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy.在癌症免疫治疗中,IL-9 产生 T 细胞的功能多样性和调控。
Cancer Lett. 2024 Dec 1;606:217306. doi: 10.1016/j.canlet.2024.217306. Epub 2024 Oct 18.
5
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.免疫细胞在肿瘤微环境中与癌细胞直接相互作用:一枚硬币的两面及其未来展望。
Front Immunol. 2024 May 22;15:1388176. doi: 10.3389/fimmu.2024.1388176. eCollection 2024.
6
Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development.肿瘤免疫微环境作为肝细胞癌发展的新治疗靶点
Dev Reprod. 2023 Dec;27(4):167-174. doi: 10.12717/DR.2023.27.4.167. Epub 2023 Dec 31.
7
HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications.HAGLR,一种在肾透明细胞癌中具有潜在抑瘤功能的长非编码 RNA:诊断和预后意义。
Mol Biotechnol. 2024 Dec;66(12):3485-3497. doi: 10.1007/s12033-023-00948-z. Epub 2023 Nov 13.
8
T cells in health and disease.健康与疾病中的 T 细胞。
Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y.
9
The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.白细胞介素-9 在肿瘤微环境中的双重作用。
J Interferon Cytokine Res. 2023 Jun;43(6):229-245. doi: 10.1089/jir.2023.0035.
10
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma.预测肝细胞癌患者免疫检查点抑制剂治疗反应的生物标志物。
Int J Mol Sci. 2023 Apr 21;24(8):7640. doi: 10.3390/ijms24087640.